<table class="wikitable"><tr><th>Name</th><th>Investigation</th><th>Route of administration</th><th>In-vitro / in-vivo</th><th>Imaging / non-imaging</th></tr><tr><td>I123-Iodide</td><td>Thyroid uptake</td><td>Oral or IV</td><td>In-vivo</td><td>Non-imaging</td></tr><tr><td>I123-Iodide</td><td>Thyroid imaging Thyroid metastases imaging</td><td>Oral or IV</td><td>In-vivo</td><td>Imaging</td></tr><tr><td>I123-o-Iodohippurate</td><td>Renal imaging</td><td>IV</td><td>In-vivo</td><td>Imaging</td></tr><tr><td>I123-MIBG (m-iodobenzylguanidine)</td><td>Neuroectodermal tumour imaging</td><td>IV</td><td>In-vivo</td><td>Imaging</td></tr><tr><td>I123-FP-CIT</td><td>SPECT imaging of Parkinson's Disease</td><td>IV</td><td>In-vivo</td><td>Imaging</td></tr></table>
